A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ETC-1002 in Subjects With Mild Dyslipidemia.
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2013
At a glance
- Drugs Bempedoic acid (Primary)
- Indications Dyslipidaemias
- Focus Adverse reactions
- Sponsors Esperion Therapeutics
- 11 Mar 2013 Results presented at the 62nd Annual Scientific Session of the American College of Cardiology.
- 19 Apr 2010 New trial record